Hanna Charbit
Jerusalem, JM, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
DNA methylation-based deconvolution study of glioblastoma heterogeneity and identification of cell compositions associated with patient survival.
Journal: Neuro-oncology advances
Published: October 25, 2025
Investigating Expression Dynamics of miR-21 and miR-10b in Glioblastoma Cells In Vitro: Insights into Responses to Hypoxia and Secretion Mechanisms.
Journal: International journal of molecular sciences
Published: June 26, 2024
Intracranial Assessment of Androgen Receptor Antagonists in Mice Bearing Human Glioblastoma Implants.
Journal: International journal of molecular sciences
Published: November 27, 2023
Rapid Classification of Sarcomas Using Methylation Fingerprint: A Pilot Study.
Journal: Cancers
Published: July 25, 2023
[18F]-FDHT PET/CT as a tool for imaging androgen receptor expression in high-grade glioma.
Journal: Neuro-oncology advances
Published: March 19, 2021
QKI-V5 is downregulated in CNS inflammatory demyelinating diseases.
Journal: Multiple sclerosis and related disorders
Published: September 12, 2019
Blood Levels of Co-inhibitory-Receptors: A Biomarker of Disease Prognosis in Multiple Sclerosis.
Journal: Frontiers in immunology
Published: December 25, 2018
Androgen receptor: a potential therapeutic target for glioblastoma.
Journal: Oncotarget
Published: November 15, 2017
Expression level of miRNAs on chromosome 14q32.31 region correlates with tumor aggressiveness and survival of glioblastoma patients.
Journal: Journal of neuro-oncology
Published: May 29, 2016
Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO).
Journal: Journal of neuroinflammation
Published: March 03, 2016
Dynamics of circulating hypoxia-mediated miRNAs and tumor response in patients with high-grade glioma treated with bevacizumab.
Journal: Journal of neurosurgery
Published: January 23, 2016
Sex-specific prediction of interferon beta therapy response in relapsing-remitting multiple sclerosis.
Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
Published: November 02, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026